Imricor Medical Systems, Inc. (IMR.AX)
- Previous Close
0.5000 - Open
0.5000 - Bid 0.4900 x 263000
- Ask 0.5100 x 264500
- Day's Range
0.4800 - 0.5000 - 52 Week Range
0.2600 - 0.8350 - Volume
55,367 - Avg. Volume
75,770 - Market Cap (intraday)
99.25M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2100 - Earnings Date Mar 4, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.90
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
www.imricor.comRecent News: IMR.AX
Performance Overview: IMR.AX
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMR.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMR.AX
Valuation Measures
Market Cap
99.25M
Enterprise Value
114.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
83.63
Price/Book (mrq)
--
Enterprise Value/Revenue
185.21
Enterprise Value/EBITDA
-5.21
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-95.73%
Return on Equity (ttm)
--
Revenue (ttm)
615.57k
Net Income Avi to Common (ttm)
-22.63M
Diluted EPS (ttm)
-0.2100
Balance Sheet and Cash Flow
Total Cash (mrq)
831.52k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-6.08M
Research Analysis: IMR.AX
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: IMR.AX
IMR.AX does not have Company Insights